Skip to main content

EACR Molecular Pathology

Novosanis will be attending the EACR-OECI Joint Virtual Conference: Molecular Pathology Approach to Cancer on March 23 - 24. Our team is excited to meet and talk with you at our virtual booth with live chat functionality. To know more about our urine collection device Colli-Pee, and its applications in oncology, watch our on-demand satellite symposium.

Register here

Disclaimer

Effective December 8th, 2024, DNA Genotek™ will be the Legal Manufacturer of the Colli-Pee™ product family.
This transfer of all Colli-Pee™ devices to DNA Genotek™ as the new Legal Manufacturer will have no impact to product performance or how you place orders for the product. Please note that this change will have no impact on the Colli-Pee™ device design or specifications and there is no change to Colli-Pee™ device fit, form or function.

The Legal Manufacturing change will only result in changes to Colli-Pee™ device labelling to list DNA Genotek™ as the Legal Manufacturer. For a limited period of time, you may receive product with labelling indicating either Novosanis™ or DNA Genotek™ as the Legal Manufacturer on the product label. Both Novosanis™ and DNA Genotek™ are subsidiaries of OraSure Technologies, Inc.